Recap: Vistagen Therapeutics Q3 Earnings
Recap: Vistagen Therapeutics Q3 Earnings
Vistagen Therapeutics (NASDAQ:VTGN) reported its Q3 earnings results on Tuesday, February 13, 2024 at 04:21 PM.
Vistagen Therapeutics（納斯達克股票代碼：VTGN）於2024年2月13日星期二下午4點21分公佈了其第三季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Vistagen Therapeutics beat estimated earnings by 26.67%, reporting an EPS of $-0.22 versus an estimate of $-0.3.
Vistagen Therapeutics的收益比預期高出26.67％，每股收益爲-0.22美元，而估計爲-0.3美元。
Revenue was up $231 thousand from the same period last year.
收入比去年同期增長了23.1萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.02 which was followed by a 11.07% drop in the share price the next day.
上個季度，該公司的每股收益超過0.02美元，隨後第二天股價下跌了11.07％。
To track all earnings releases for Vistagen Therapeutics visit their earnings calendar here.
要追蹤Vistagen Therapeutics發佈的所有業績，請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。